Two doses of Sinovac provide 97.2 pct protection, says expert – Türkiye News
ANKARA The results of the Phase 3 studies of Sinovac in Türkiye have been announced after the 164-day follow-up, as
Read MoreANKARA The results of the Phase 3 studies of Sinovac in Türkiye have been announced after the 164-day follow-up, as
Read MoreCoronavirus latest: AstraZeneca antibody drug offers 83% protection over 6 months Nikkei Asia AstraZeneca’s antibody cocktail helps prevent COVID-19 for at
Read More